NRP1 and breast carcinoma: One such study demonstrated that VEGF acted as an autocrine survival factor for NRP-1-expressing breast cancer cells, protecting them from hypoxia-induced apoptosis in the absence of VEGFR-2 expression through activation of the phosphatidylinositol 3′-kinase pathway (Bachelder et al, 2001).